What is GI Windows?
Founded in 2012 and headquartered in Westwood, Massachusetts, GI Windows is dedicated to advancing anastomoses technology within the medical device sector. The company's focus on this critical area of surgical connection technology positions it as a key player in developing solutions that aim to improve patient outcomes and procedural efficiency. The substantial enterprise-level funding suggests a company poised for significant scaling and market penetration.
How much funding has GI Windows raised?
GI Windows has raised a total of $53.4M across 2 funding rounds:
Series A
$16.4M
Series B
$37M
Series A (2020): $16.4M with participation from Sonder Capital, GT Healthcare Capital Partners, JC Investco, and Johnson & Johnson Innovation – JJDC, Inc.
Series B (2024): $37M led by JCInvestco, Orlando Health, and Rex Health Ventures
Key Investors in GI Windows
Orlando Health
Orlando Health is a comprehensive, not-for-profit healthcare organization headquartered in Orlando, Florida. Serving Central Florida and beyond, it operates 17 hospitals, including the Orlando Regional Medical Center, Arnold Palmer Hospital for Children, and South Lake Hospital, among others. Additionally, Orlando Health manages over 200 outpatient locations, including emergency rooms, medical pavilions, and physician practices.
Rex Health Ventures
Rex Health Ventures (RHV) is an innovative platform established by UNC REX Healthcare to support and invest in healthcare technologies and companies. As an early-stage investment fund, it aims to enhance patient care by providing strategic investments to emerging healthcare entrepreneurs across North Carolina and the U.S. The organization leverages expertise from the UNC REX and UNC Health Care network to foster groundbreaking advancements in health. Founded in 2012, RHV is committed to driving breakthrough innovations in the healthcare sector.
GT Healthcare Capital Partners
GT Healthcare Capital Partners is a venture capital company. It specializes in healthcare investments around the globe. The company is based in Central, Hong Kong.
What's next for GI Windows?
The recent major strategic investment indicates GI Windows is likely entering a phase of accelerated growth and market expansion. This capital infusion will probably be directed towards further research and development, scaling manufacturing capabilities, and broadening commercialization efforts. The company's focus on anastomoses technology suggests potential applications in various surgical fields, and this funding will enable GI Windows to solidify its position and potentially introduce next-generation devices to the healthcare market.
See full GI Windows company page
